Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers

Skin Pharmacology and Physiology

Volumn 20, Issue 3, 2007, Pages 133-140

  Gorne R C ^a   Greif, C ^b   Metzner, U ^b   Wigger Alberti, W ^b   Elsner, P ^b  

^a Friedrich Schiller University ^*

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Chromametry; Topical steroids; Vasoconstriction assay

Indexed keywords

BAMIPINE; CLOBETASOL PROPIONATE; HYDROCORTISONE; HYDROCORTISONE ACETATE; HYDROGALEN; PLACEBO; TOLNAFTATE; UNCLASSIFIED DRUG;

ACNE; ADULT; ARTICLE; ATROPHY; CLINICAL TRIAL; COLORIMETRY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; STRIA; TELANGIECTASIA; VASOCONSTRICTION;

ADMINISTRATION, CUTANEOUS; ADULT; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL ASSAY; CHEMISTRY, PHARMACEUTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; OINTMENTS; PILOT PROJECTS; REFERENCE STANDARDS; SKIN; SKIN ABSORPTION; TIME FACTORS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 34249089264     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098164     Document Type: Article

References (23)

1. McKenzie AW, Stoughton RB: Method for comparing percutaneous absorption of steroids. Arch Dermatol 1962;86:608-610.
2. Olsen EA: A double-blind controlled comparison of generic and tradename topical steroids using the vasoconstrictions assay. Arch Dermatol 1991;127:197-201.
3. Reid J, Brookes DB: Topical corticosteroids - an experimental evaluation of the vasoconstrictor test as an index of anti-inflammatory activity. Br J Dermatol 1968;80:328-336.
4. Elsner P: Chromametrie. Hardware, measuring principles and standardization of measurements; in Beradesca E, Elsner P, Maibach HI (eds): Handbooks of Skin Bioengineering. Cutaneous Blood Flow and Erythema. Boca Raton, CRC Press, 1994.
5. McKenzie AW: Percutaneous absorption of steroids. Arch Dermatol 1972;86:911.
6. Sarkany I, Hadgraft JW, Caron GA, Barrett CW: The role of vehicles in the percutaneous absorption of corticosteroids. An experimental and clinical study. Br J Dermatol 1965;77:569-575.
7. Clary P, Wets L, Barel A, Gabard B: The skin blanching assay with halcinonide, influence of halcinonide concentration and application time. J Eur Acad Dermatol Venereol 1995;5:250-257.
8. Stoughton RB: Are generic formulations equivalent to brand name topical glucocorticosteroids? Arch Dermatol 1987;121:1312-1314.
9. Stoughton RB: Are topical glucocorticosteroids equivalent to the brand name? J Am Acad Dermatol 1988;18:138-139.
10. Stoughton RB: Bioassay systems for formulation of topical applied glucocorticosteroids. Arch Dermatol 1972;106:825.
11. Stoughton RB: Vasoconstrictor activity and percutaneous absorption of glucocorticosteroids. Arch Dermatol 1969;99:753-756.
12. Maibach HI: In vivo percutaneous penetration of corticoids in man and unresolved problems in their efficacy. Dermatologica 1976;152(suppl 1):11-25.
13. Polano MK, Ponec M: Dependence of corticosteroid penetration on the vehicle. Arch Dermatol 1976;112:675-680.
14. Zesch A, Schaefer H: Penetration kinetics of four drugs in the human skin. Influences of various pharmaceutical vehicles on penetration in vitro. Acta Derm Venereol 1974;54:91-97.
15. Barry BW, Bennett SL: Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progesterone through human skin. J Pharm Pharmacol 1987;39:535-546.
16. Aungst BJ, Blake JA, Hussain MA: Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines. Pharm Res 1990;7:712-718.
17. Gloor M, Bettinger J, Gehring W: Modification of stratum corneum quality by glycerin-containing external ointments. Hautarzt 1998:49:6-9.
18. Polano MK, Ponec M, Smeenk G, Hendrikse JC: Factors influencing the penetration of corticosteroids through the epidermis. Adv Biol Skin 1972;12:325-338.
19. Song JF, Lau-Cam CA, Kim KH: Monohydroxylation and esterification as determinants of the effects of cis and trans-9-octadecenoic acids on the permeation of hydrocortisone and 5-fluorouracil across hairless mouse skin in vitro. Int J Pharm 2001;212:153-160.
20. Kogan A, Garti N: Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interface Sci 2006, Epub ahead of print.
21. CIELAB-System: http://www.linocolor.com/colorman/sp_ciela_11.htm.
22. Bettinger J, Gloor M, Peter C, Kleesz P, Fluhr J, Gehring W: Opposing effects of glycerol on the protective function of the layer against irritants and on the penetration of hexyl nicotinat. Dermatology 1998;197:18-24.
23. Demana PH, Smith EW, Walker RB, Haigh JM, Kanfer I: Evaluation of the proposed FDA pilot dose-response methodology for topical corticosteroid bioequivalence testing. Pharm Res 1997;3:303-308.